KBR Inc. (KBR), Autohome Inc. (ADR) (ATHM) & More: Here’s Why These Stocks Are on Investors’ Radars

Page 2 of 2

Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) stock has declined after the company yesterday provided an update about the clinical study for NY-ESO SPEAR® T-cell therapy for treating ovarian cancer patients with treatment resistant or refractory metastatic ovarian cancer. The company has changed the protocol to include both fludarabine and cyclophosphamide in the conditioning regimen. Fludarabine  has been linked to deaths in an earlier trial conducted by Juno Therapeutics. Adaptimmune Therapeutics is now actively recruiting subjects for its study. A total of 14 funds tracked by us reported stakes in Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) worth $43 million in aggregate as of the end of June, which compares to 16 funds and $40 million, respectively, a quarter earlier.

Follow Adaptimmune Therapeutics Plc (NASDAQ:ADAP)

Shares of Embraer SA (ADR) (NYSE:ERJ) are over 4% in the green as the company reported nearing the settlement for its corruption investigation. The company is currently being scrutinized by Brazilian and US investigators and the settlement may include fines, a deferred prosecution agreement and the appointment of an independent monitor for assessing compliance. Embraer has kept $200 million in reserve for meeting possible settlement charges. At the end of June, there were 10 funds from our database that amassed around $91 million of Embraer stock, compared to eight funds holding stock worth $131 million a quarter earlier.

Follow Embraer S A (NYSE:ERJ)

Fiat Chrysler Automobiles NV (NYSE:FCAU) stock slumped as the company’s negotiations with Samsung stalled following Galaxy Note 7 smartphone fiasco. Fiat Chrysler Automobiles was looking to enter into a partnership with Samsung for car-parts and, while the deal is still believed to be on, it is unlikely to be finalized by the end of 2016, as it was planned earlier. The number of funds tracked by Insider Monkey that held shares of Fiat Chrysler Automobiles NV (NYSE:FCAU) inched down by one to 27 during the second quarter and the total value of their positions fell to $534 million from $645 million.

Disclosure: none

Page 2 of 2